ALDEYRA THERAPEUTICSCS INC
ALDEYRA THERAPEUTICSCS INC
Share · US01438T1060 · ALDX · A111X8 (XNAS)
Overview Financial Indicators
2,83 USD
-3,08 % -0,09 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
13.06.2025 22:37

Current Prices from ALDEYRA THERAPEUTICSCS INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
ALDX
USD
13.06.2025 22:37
2,83 USD
2,92 USD
-3,08 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 8,43 % 30,41 % -59,04 % -42,24 % -24,13 % -37,39 %

Company Profile for ALDEYRA THERAPEUTICSCS INC Share

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical trial for psoriasis, asthma, and COVID-19; and ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of retinitis pigmentosa, as well as for treating primary vitreoretinal lymphoma. The company has a license agreement with Madrigal Pharmaceuticals, Inc. for developing ADX-1612, which inhibits the protein chaperome for the treatment of inflammatory diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

Company Data

Name ALDEYRA THERAPEUTICSCS INC
Company Aldeyra Therapeutics, Inc.
Symbol ALDX
Website https://www.aldeyra.com
Primary Exchange XNAS NASDAQ
WKN A111X8
ISIN US01438T1060
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Todd C. Brady M.D., Ph.D.
Market Capitalization 129 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 131 Hartwell Avenue, 02421 Lexington
IPO Date 2014-05-02

Ticker Symbols

Name Symbol
Frankfurt 137.F
NASDAQ ALDX

More Shares

Investors who ALDEYRA THERAPEUTICSCS INC hold also have the following shares in their portfolio:
ACTIVISION BLIZZARD INC
ACTIVISION BLIZZARD INC Share
ADVANCED MICRO DEVICES INC
ADVANCED MICRO DEVICES INC Share
Alpha Cognition Inc. - Common Stock
Alpha Cognition Inc. - Common Stock Share
AMAZON.CO INC
AMAZON.CO INC Share
APPLE INC
APPLE INC Share
AUTODESK INC
AUTODESK INC Share
BEIJING ENTERPRISES
BEIJING ENTERPRISES Share
BTCST
BTCST Crypto
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
INFINEON TECHNOLOGIESLOGIES AG
INFINEON TECHNOLOGIESLOGIES AG Share
INTEL CORP
INTEL CORP Share
ISHARES MSCI EMERGING MARKETS ASIA ETF
ISHARES MSCI EMERGING MARKETS ASIA ETF ETF
MICROSOFT CORP
MICROSOFT CORP Share
NVIDIA CORP
NVIDIA CORP Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025